Search Results - "FORLER, P"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Treatment Regimens Including the Multitargeted Antifolate LY231514 in Human Tumor Xenografts by Teicher, B A, Chen, V, Shih, C, Menon, K, Forler, P A, Phares, V G, Amsrud, T

    Published in Clinical cancer research (01-03-2000)
    “…The scheduling of antifolate antitumor agents, including the new multitargeted autofolate LY231514 (MTA), with 5-fluorouracil was explored in the human MX-1…”
    Get full text
    Journal Article
  2. 2

    Antitumor activity of cryptophycins: effect of infusion time and combination studies by MENON, K, ALVAREZ, E, FORLER, P, PHARES, V, AMSRUD, T, SHIH, C, AL-AWAR, R, TEICHER, B. A

    “…Cryptophycins are a family of antitubulin antitumor agents. A synthetic cryptophycin derivative (LY355703, CRYPTO 52) is in early clinical evaluation. The…”
    Get full text
    Journal Article
  3. 3

    Cryptophycin 52 and cryptophycin 55 in sequential and simultaneous combination treatment regimens in human tumor xenografts by Teicher, B A, Forler, P, Menon, K, Phares, V, Amsrud, T, Shih, C

    Published in In vivo (Athens) (01-07-2000)
    “…The antitumor activity of cryptophycin 52 (C52) and cryptophycin 55 (C55) in sequential and simultaneous combination treatment regimens in human tumor…”
    Get more information
    Journal Article